• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与新型阳离子佐剂复合的乳酸奈瑟菌抗原

Neisseria lactamica antigens complexed with a novel cationic adjuvant.

作者信息

Gaspar Emanuelle B, Rosetti Andreza S, Lincopan Nilton, De Gaspari Elizabeth

机构信息

Embrapa Southern Region Animal Husbandry; Bagé, RS Brazil; Institute of Biomedical Sciences; Department of Microbiology; University of São Paulo; São Paulo, SP Brazil.

出版信息

Hum Vaccin Immunother. 2013 Mar;9(3):572-81. doi: 10.4161/hv.23237. Epub 2013 Jan 7.

DOI:10.4161/hv.23237
PMID:23296384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3891714/
Abstract

Colonization of the nasopharynx by non-pathogenic Neisseria species, including N. lactamica, has been suggested to lead to the acquisition of natural immunity against Neisseria meningitidis in young children. The aim of this study was to identify a model complex of antigens and adjuvant for immunological preparation against N. meningitidis B, based on cross reactivity with N. lactamica outer membrane vesicles (OMV) antigens and the (DDA-BF) adjuvant. Complexes of 25 µg of OMV in 0.1 mM of DDA-BF were colloidally stable, exhibiting a mean diameter and charge optimal for antigen presentation. Immunogenicity tests for these complexes were performed in mice. A single dose of OMV/DDA-BF was sufficient to induce a (DTH) response, while the same result was achieved only after two doses of OMV/alum. In addition, to achieve total IgG levels that are similar to a single immunization with OMV/DDA-BF, it was necessary to give the mice a second dose of OMV/alum. Moreover, the antibodies induced from a single immunization with OMV/DDA-BF had an intermediate avidity, but antibodies with a similar avidity were only induced by OMV/alum after two immunizations. The use of this novel cationic adjuvant for the first time with a N. lactamica OMV preparation revealed good potential for future vaccine design.

摘要

包括乳酸奈瑟菌在内的非致病性奈瑟菌属在鼻咽部的定植,被认为可使幼儿获得针对脑膜炎奈瑟菌的天然免疫力。本研究的目的是基于与乳酸奈瑟菌外膜囊泡(OMV)抗原和(DDA-BF)佐剂的交叉反应,确定一种用于制备抗B型脑膜炎奈瑟菌免疫制剂的抗原和佐剂复合模型。25 µg OMV与0.1 mM DDA-BF形成的复合物具有胶体稳定性,其平均直径和电荷最适合抗原呈递。在小鼠中对这些复合物进行了免疫原性测试。单剂量的OMV/DDA-BF足以诱导迟发型超敏反应(DTH),而同样的结果只有在两剂OMV/明矾后才能实现。此外,为了达到与单剂量OMV/DDA-BF免疫相似的总IgG水平,有必要给小鼠注射第二剂OMV/明矾。而且,单剂量OMV/DDA-BF免疫诱导的抗体具有中等亲和力,但只有在两次免疫后,OMV/明矾才能诱导出具有相似亲和力的抗体。首次将这种新型阳离子佐剂与乳酸奈瑟菌OMV制剂联合使用,显示出其在未来疫苗设计中的良好潜力。

相似文献

1
Neisseria lactamica antigens complexed with a novel cationic adjuvant.与新型阳离子佐剂复合的乳酸奈瑟菌抗原
Hum Vaccin Immunother. 2013 Mar;9(3):572-81. doi: 10.4161/hv.23237. Epub 2013 Jan 7.
2
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.基于乳酸奈瑟菌外膜囊泡的候选脑膜炎球菌病疫苗的I期安全性和免疫原性研究。
Clin Vaccine Immunol. 2009 Aug;16(8):1113-20. doi: 10.1128/CVI.00118-09. Epub 2009 Jun 24.
3
Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant.乳酸奈瑟菌外膜囊泡作为一种潜在的黏膜佐剂。
Vaccine. 2006 Jan 12;24(2):206-14. doi: 10.1016/j.vaccine.2005.07.064. Epub 2005 Aug 8.
4
Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.基于乳酸奈瑟菌外膜囊泡的脑膜炎球菌病疫苗关键抗原成分的表征及临床前免疫反应
Hum Vaccin. 2008 Jan-Feb;4(1):23-30. doi: 10.4161/hv.4.1.4806. Epub 2007 Jul 29.
5
Dioctadecyldimethylammonium bromide (DODAB-BF) as a new adjuvant for maternal-fetal immunization in mice against Neisseria meningitidis: evaluation of humoral response.双十八烷基二甲基溴化铵(DODAB-BF)作为一种新佐剂在小鼠中的应用:用于母婴免疫接种以预防脑膜炎奈瑟菌的体液免疫反应评价。
Pathog Dis. 2018 Feb 1;76(1). doi: 10.1093/femspd/ftx128.
6
Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.解脲奈瑟菌鼻咽部定植及诱导奈瑟脑膜炎奈瑟菌保护性免疫
Clin Infect Dis. 2011 Jan 1;52(1):70-7. doi: 10.1093/cid/ciq065.
7
Immunogenicity of antigens from outer membrane vesicles of associated with bilayer fragment of dioctadecyldimethylammonium in Swiss adult mice.与二辛基二甲基氯化铵双层片段相关的外膜囊泡抗原在瑞士成年小鼠中的免疫原性。
Clin Exp Vaccine Res. 2021 May;10(2):106-122. doi: 10.7774/cevr.2021.10.2.106. Epub 2021 May 31.
8
Evaluation of intranasal and subcutaneous route of immunization in neonatal mice using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria meningitis B.使用二油酰基二甲基氯化铵-硼氟化物(DODAB-BF)作为佐剂与B型脑膜炎奈瑟菌外膜囊泡对新生小鼠进行鼻内和皮下免疫途径的评估。
Immunobiology. 2018 Dec;223(12):750-760. doi: 10.1016/j.imbio.2018.07.021. Epub 2018 Jul 19.
9
Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.乳酸奈瑟菌和脑膜炎奈瑟菌外膜囊泡疫苗抗原的蛋白质组学分析
Vaccine. 2006 Jun 19;24(25):5277-93. doi: 10.1016/j.vaccine.2006.03.013. Epub 2006 Mar 23.
10
The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.基于乳酸奈瑟菌外膜囊泡的脑膜炎球菌病疫苗的研发。
Vaccine. 2005 Mar 18;23(17-18):2210-3. doi: 10.1016/j.vaccine.2005.01.055.

引用本文的文献

1
Optimization of methods for isolation and purification of outer membrane vesicles (OMVs) from Neisseria lactamica.从乳酸奈瑟菌中分离和纯化外膜囊泡(OMV)方法的优化。
Appl Microbiol Biotechnol. 2025 Apr 7;109(1):82. doi: 10.1007/s00253-025-13460-y.
2
Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from .溴化二甲基二十八烷基铵和皂苷作为[具体来源]外膜囊泡佐剂的免疫学效应
Diseases. 2022 Jul 19;10(3):46. doi: 10.3390/diseases10030046.
3
Immunogenicity of antigens from outer membrane vesicles of associated with bilayer fragment of dioctadecyldimethylammonium in Swiss adult mice.与二辛基二甲基氯化铵双层片段相关的外膜囊泡抗原在瑞士成年小鼠中的免疫原性。
Clin Exp Vaccine Res. 2021 May;10(2):106-122. doi: 10.7774/cevr.2021.10.2.106. Epub 2021 May 31.
4
Avidity assay to test functionality of anti-SARS-Cov-2 antibodies.用于测试抗SARS-CoV-2抗体功能的亲和力测定。
Vaccine. 2021 Mar 5;39(10):1473-1475. doi: 10.1016/j.vaccine.2021.02.003. Epub 2021 Feb 3.

本文引用的文献

1
Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.人类预防性疫苗佐剂及其在新型疫苗配方中的决定作用。
Braz J Med Biol Res. 2012 Aug;45(8):681-92. doi: 10.1590/s0100-879x2012007500067. Epub 2012 Apr 26.
2
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study.在智利健康青少年中,一种包含多种脑膜炎奈瑟菌 B 群(4CMenB)组份的疫苗的免疫原性和耐受性:一项 2b/3 期、随机、观察者盲、安慰剂对照研究。
Lancet. 2012 Feb 18;379(9816):617-24. doi: 10.1016/S0140-6736(11)61713-3. Epub 2012 Jan 18.
3
Meningococcal vaccines: WHO position paper, November 2011.脑膜炎球菌疫苗:世界卫生组织立场文件,2011年11月
Wkly Epidemiol Rec. 2011 Nov 18;86(47):521-39.
4
A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.一项评估幼儿使用不同配方的四价脑膜炎球菌(A、C、Y 和 W-135)结合破伤风蛋白疫苗的安全性和免疫原性的随机试验。
Pediatr Infect Dis J. 2012 Jan;31(1):e15-23. doi: 10.1097/INF.0b013e31823e1e34.
5
Gram-negative outer membrane vesicles in vaccine development.疫苗研发中的革兰氏阴性菌外膜囊泡
Discov Med. 2011 Jul;12(62):7-15.
6
Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.解脲奈瑟菌鼻咽部定植及诱导奈瑟脑膜炎奈瑟菌保护性免疫
Clin Infect Dis. 2011 Jan 1;52(1):70-7. doi: 10.1093/cid/ciq065.
7
A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA.A 组脑膜炎奈瑟菌天然外膜囊泡疫苗的 1 期研究,该疫苗由 lpxL2 和 synX 缺失且 opcA 稳定表达的菌株制成。
Vaccine. 2010 Oct 8;28(43):6970-6. doi: 10.1016/j.vaccine.2010.08.048. Epub 2010 Aug 21.
8
Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo.基于阳离子脂质的新型免疫佐剂:体内制备、表征及活性
Vaccine. 2009 Sep 25;27(42):5760-71. doi: 10.1016/j.vaccine.2009.07.066. Epub 2009 Aug 5.
9
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.基于乳酸奈瑟菌外膜囊泡的候选脑膜炎球菌病疫苗的I期安全性和免疫原性研究。
Clin Vaccine Immunol. 2009 Aug;16(8):1113-20. doi: 10.1128/CVI.00118-09. Epub 2009 Jun 24.
10
Homologous prime-boost strategy in neonate mice using Neisseria lactamica.
Vaccine. 2009 May 26;27(25-26):3422-8. doi: 10.1016/j.vaccine.2009.01.114. Epub 2009 Jan 31.